Matthieu Blanchet

Laval, QC H7V1B7, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Exosomes as Conduits: Facilitating Hepatitis B Virus-Independent Hepatitis D Virus Transmission and Propagation in Hepatocytes.

Exosomes as Conduits: Facilitating Hepatitis B Virus-Independent Hepatitis D Virus Transmission and Propagation in Hepatocytes.

Journal: Viruses
Published: April 16, 2024

HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression.

HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression.

Journal: Viruses
Published: February 28, 2024

Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen.

Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen.

Journal: PloS one
Published: June 13, 2023

Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro.

Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro.

Journal: Antiviral research
Published: January 20, 2020

Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.

Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.

Journal: Journal of virology
Published: November 15, 2019

Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells.

Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells.

Journal: Antiviral research
Published: December 18, 2018

LC3B is not recruited along with the autophagy elongation complex (ATG5-12/16L1) at HCV replication site and is dispensable for viral replication.

LC3B is not recruited along with the autophagy elongation complex (ATG5-12/16L1) at HCV replication site and is dispensable for viral replication.

Journal: PloS one
Published: June 08, 2018

Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection In Vitro.

Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection In Vitro.

Journal: Journal of virology
Published: August 21, 2017

Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.

Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.

Journal: PloS one
Published: March 30, 2017

Statins can exert dual, concentration dependent effects on HCV entry in vitro.

Statins can exert dual, concentration dependent effects on HCV entry in vitro.

Journal: Antiviral research
Published: July 16, 2015

Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9.

Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9.

Journal: The Journal of biological chemistry
Published: February 03, 2015

SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection.

SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection.

Journal: Antiviral research
Published: October 09, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026